`Patent No. 9,393,208
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MYLAN PHARMACEUTICALS INC.
`Petitioner
`
`v.
`
`POZEN INC. and HORIZON PHARMA USA, INC.
`Patent Owners
`
`Case No. IPR2018-00272
`Patent No. 9,393,208
`
`PATENT OWNERS EXHIBIT LIST
`
`
`
`Case No. IPR2018-00272
`Patent No. 9,393,208
`
`PATENT OWNERS EXHIBIT LIST
`
`Exhibit Number
`
`Description of Document
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`Gabriel, S.E., et al., “Risk for Serious Gastrointestinal
`Complications Related to Use of Nonsteroidal Anti-
`inflammatory Drugs,” Annals of Internal Medicine, Vol.
`115, No. 10, pp. 787-796 (1991) (“Gabriel”)
`
`Cryer, B. and Feldman, M., “Effects of Nonsteroidal
`Anti-inflammatory Drugs on Endogenous
`Gastrointestinal Prostaglandins and Therapeutic
`Strategies for Prevention and Treatment of Nonsteroidal
`Anti-inflammatory Drug-Induced Damage,” Archives of
`Internal Medicine, Vol. 152, pp. 1145-1155 (1992)
`(“Cryer”)
`
`Fries, J.F., et al., “Nonsteroidal Anti-Inflammatory Drug-
`Associated Gastropathy: Incidence and Risk Factor
`Models,” The American Journal of Medicine, Vol. 91,
`pp. 213-222 (1991) (“Fries”)
`
`U.S. Patent No. 9,220,698 Prosecution History Excerpt:
`Response to Final Office Action Mailed March 26, 2015
`(Sept. 25, 2015)
`
`U.S. Patent No. 9,220,698 Prosecution History Excerpt:
`Advisory Action (Oct. 9, 2015)
`
`Pozen Inc. Bankruptcy Petition dated August 10, 2018
`
`///
`
`///
`
`///
`
`///
`
`2
`
`
`
`Date: September 4, 2018
`
`Case IPR2018-00272
`Patent 9,393,208
`Patent Owners Exhibit List
`
`Respectfully submitted,
`
`By: /s/Margaret Sampson
`
`Margaret Sampson
`BAKER BOTTS LLP
`98 San Jacinto Blvd. Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2500
`Fax: (512) 322-2501
`margaret.sampson@bakerbotts.com
`USPTO Reg. No. 47,052
`
`COUNSEL FOR PATENT
`OWNER POZEN INC.
`
`3
`
`
`
`Case IPR2018-00272
`Patent 9,393,208
`Patent Owners Exhibit List
`
`By: /s/Margaret Sampson
`Margaret Sampson
`USPTO Reg. No. 47,052
`
`COUNSEL FOR PATENT
`OWNER POZEN INC.
`
`for PATENT OWNER HORIZON:
`Thomas A. Blinka, Ph.D.
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W.,
`Suite 700
`Washington, DC 20004-2400
`Tel: (202) 842-7800
`Fax: (202) 842-7899
`TBlinka@cooley.com
`
`Jonathan G. Graves
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W., Suite 700
`Washington, DC 20004-2400
`Tel: (703) 456-8119
`Fax: (703) 456-8100
`JGraves@cooley.com
`
`Ellen Scordino
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W., Suite 700
`Washington, DC 20004-2400
`Tel: (617) 937-2492
`Fax: (617) 937-2400
`EScordino@cooley.com
`
`Date: September 4, 2018
`
`4
`
`
`
`Case IPR2018-00272
`Patent 9,393,208
`Patent Owners Exhibit List
`
`CERTIFICATE OF SERVICE
`
`I, Margaret Sampson, hereby certify that on this 4th day of September
`
`2018, the
`
`foregoing PATENT OWNERS EXHIBIT LIST was served via
`
`email on the following:
`
`for PETITIONER MYLAN:
`Brandon M. White
`PERKINS COIE LLP
`700 13th St., NW Suite 600
`Washington, DC 20005
`bmwhite@perkinscoie.com
`
`EsoNaproxen@perkinscoie.com
`
`Emily J. Greb
`PERKINS COIE LLP
`One East Main St., Suite 201
`Madison, WI 53703
`egreb@perkinscoie.com
`
`5
`
`